Avita Medical Inc. (ASX:AVH) Share Market Overview and Biotechnology Sector Profile

Anjali Anand

11 August 2026 11:19 PM AEST

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Key Highlights

Avita Medical Inc. (ASX:AVH) shares traded at $2.130 during the latest trading session.
The company recorded a daily share price increase of 4.926%, with trading Volume of 1,338,489 shares.
Avita Medical Inc. recorded a Market Capitalisation of $313.90M.
The stock traded within a daily range of $1.995 to $2.140.
AVH shares recorded a 52-week trading range between $1.000 and $2.140.

Avita Medical Inc. (ASX:AVH) Market Overview

Avita Medical Inc. (ASX:AVH) is an Australian Securities Exchange-listed company operating within the pharmaceuticals, biotechnology and life sciences industry group.

The company’s shares were trading at $2.130, recording a daily movement of +4.926%. This article provides an educational overview of Avita Medical’s market information, including share price activity, trading volume, market capitalisation and key share statistics.

Share Price Movement and Trading Activity

Avita Medical Inc. recorded a share price of $2.130 during the latest trading session, compared with the previous close of $2.030. The stock increased by $0.100, representing a daily movement of 4.926%.

During the session, AVH shares traded within a range of $1.995 to $2.140. The company recorded trading volume of 1,338,489 shares, while the average trading volume was 418,036 shares.

Trading volume reflects the number of shares exchanged during a Trading session and is commonly reviewed alongside share price changes to understand market participation.

Market Capitalisation and Share Information

Avita Medical Inc. recorded a market capitalisation of $313.90M. Market capitalisation represents the total Market Value of a company’s listed shares based on its share price and shares outstanding.

The company has 154,634,235 shares on issue. Its listed securities are structured as Chess Depositary Interests with a 5:1 ratio.

The company’s International Securities Identification Number (ISIN) is AU000000AVH4.

Historical Trading Range

Avita Medical Inc. shares recorded a 52-week trading range between $1.000 and $2.140.

The 52-week range provides a historical reference of the highest and lowest prices recorded by the stock over the previous year. This measure is commonly used to review share price movements over a defined period.

The stock’s current trading level is positioned within its recorded yearly range, reflecting market activity across the previous 12 months.

Pharmaceuticals, Biotechnology and Life Sciences Sector

Avita Medical Inc. is classified within the pharmaceuticals, biotechnology and life sciences industry group. This sector includes companies involved in healthcare-related research, technologies, products and development activities.

Companies operating within this industry can experience market movements influenced by factors such as scientific developments, regulatory processes, industry conditions and broader market participation.

For listed biotechnology companies, Market Indicators including share price movement, trading volume and market capitalisation are commonly monitored alongside company announcements and financial disclosures.

Listing History and Market Information

Avita Medical Inc. was listed on the Australian Securities Exchange on 24 June 2020.

The company’s securities trade under the ticker code ASX:AVH. Its market profile includes daily trading activity, share price movement, historical trading range and market capitalisation.

These indicators provide a snapshot of the company’s listed market activity and allow investors and market observers to track changes in trading patterns over time.

Understanding ASX Biotechnology Market Data

Biotechnology companies often operate in sectors where market activity can be influenced by research developments, regulatory milestones and broader healthcare industry conditions.

Share price, trading volume, market capitalisation and historical price ranges are among the commonly reviewed indicators for listed securities. These metrics provide information about market activity but do not represent a complete assessment of a company’s operations or financial position.

Additional information from company reports, announcements and official disclosures may provide further details about Business activities and developments.

Conclusion

Avita Medical Inc. (ASX:AVH) recorded a share price of $2.130, with a daily increase of 4.926% and trading volume of 1,338,489 shares. The company recorded a market capitalisation of $313.90M and operates within the pharmaceuticals, biotechnology and life sciences industry group. With a 52-week trading range of $1.000 to $2.140, AVH’s market activity reflects movements in its listed securities within the Australian Equity market. This article provides an educational overview of available market information and does not constitute financial advice or Investment recommendations.

FAQs

Q: What is the ASX ticker code for Avita Medical Inc.?

A:Avita Medical Inc. is listed on the Australian Securities Exchange under the ticker code ASX:AVH.

Q: What was Avita Medical Inc.’s latest share price?

A:Avita Medical Inc. shares were trading at $2.130.

Q: What was the daily share price movement for ASX:AVH?

A:The company recorded a daily share price increase of 4.926%.

Q: What is Avita Medical Inc.’s market capitalisation?

A:Avita Medical Inc. recorded a market capitalisation of $313.90M.

Q: Which industry group does Avita Medical Inc. belong to?

A:Avita Medical Inc. belongs to the pharmaceuticals, biotechnology and life sciences industry group.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.